Kelsey Flint
Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Failure | 26 | 2024 | 2093 | 5.200 |
Why?
| | Cardiac Rehabilitation | 4 | 2020 | 43 | 2.240 |
Why?
| | Heart-Assist Devices | 8 | 2020 | 561 | 2.120 |
Why?
| | Stroke Volume | 7 | 2024 | 590 | 1.800 |
Why?
| | Frailty | 4 | 2021 | 176 | 1.630 |
Why?
| | Malnutrition | 2 | 2024 | 84 | 1.530 |
Why?
| | Health Status | 5 | 2020 | 820 | 1.490 |
Why?
| | Quality of Life | 8 | 2020 | 3005 | 1.140 |
Why?
| | Frail Elderly | 4 | 2020 | 132 | 1.050 |
Why?
| | Ventricular Dysfunction, Left | 2 | 2017 | 375 | 0.750 |
Why?
| | Mitral Valve Insufficiency | 2 | 2020 | 73 | 0.730 |
Why?
| | Geriatric Assessment | 2 | 2019 | 225 | 0.660 |
Why?
| | Shock, Cardiogenic | 2 | 2020 | 59 | 0.620 |
Why?
| | Mitral Valve | 2 | 2020 | 98 | 0.600 |
Why?
| | Mitral Valve Annuloplasty | 1 | 2019 | 4 | 0.600 |
Why?
| | Heart | 2 | 2022 | 620 | 0.600 |
Why?
| | Cardiology | 1 | 2022 | 279 | 0.600 |
Why?
| | Multimorbidity | 1 | 2019 | 54 | 0.590 |
Why?
| | Spirituality | 1 | 2019 | 85 | 0.560 |
Why?
| | Exercise Therapy | 3 | 2022 | 450 | 0.540 |
Why?
| | Walking Speed | 1 | 2018 | 50 | 0.530 |
Why?
| | Health Status Indicators | 2 | 2020 | 161 | 0.530 |
Why?
| | Aged | 19 | 2024 | 24666 | 0.510 |
Why?
| | Registries | 4 | 2019 | 2143 | 0.500 |
Why?
| | Cardiac Pacing, Artificial | 1 | 2016 | 78 | 0.490 |
Why?
| | Cardiovascular Diseases | 2 | 2020 | 2082 | 0.470 |
Why?
| | Pacemaker, Artificial | 1 | 2016 | 117 | 0.450 |
Why?
| | Humans | 36 | 2024 | 140898 | 0.420 |
Why?
| | Natriuretic Peptide, Brain | 1 | 2014 | 103 | 0.410 |
Why?
| | Depression | 3 | 2024 | 1487 | 0.410 |
Why?
| | Ventricular Function, Left | 1 | 2017 | 515 | 0.410 |
Why?
| | Hand Strength | 1 | 2014 | 132 | 0.400 |
Why?
| | Preoperative Period | 1 | 2013 | 143 | 0.400 |
Why?
| | Outpatients | 1 | 2016 | 418 | 0.390 |
Why?
| | Patient Readmission | 2 | 2017 | 707 | 0.370 |
Why?
| | Heart Ventricles | 1 | 2017 | 749 | 0.360 |
Why?
| | Anxiety | 1 | 2019 | 1076 | 0.360 |
Why?
| | Aged, 80 and over | 7 | 2024 | 7899 | 0.330 |
Why?
| | Myocardial Infarction | 1 | 2018 | 1069 | 0.330 |
Why?
| | Treatment Outcome | 7 | 2020 | 11125 | 0.310 |
Why?
| | Female | 20 | 2024 | 75540 | 0.290 |
Why?
| | Hospitalization | 3 | 2024 | 2261 | 0.290 |
Why?
| | Patient Selection | 1 | 2012 | 684 | 0.280 |
Why?
| | Male | 18 | 2024 | 69893 | 0.260 |
Why?
| | Symptom Assessment | 2 | 2019 | 130 | 0.260 |
Why?
| | United States | 9 | 2024 | 15195 | 0.250 |
Why?
| | Patient Reported Outcome Measures | 2 | 2020 | 437 | 0.240 |
Why?
| | Natriuresis | 1 | 2024 | 13 | 0.220 |
Why?
| | Age Factors | 4 | 2019 | 3278 | 0.220 |
Why?
| | Sodium Potassium Chloride Symporter Inhibitors | 1 | 2024 | 16 | 0.220 |
Why?
| | Recovery of Function | 2 | 2019 | 680 | 0.210 |
Why?
| | Mineralocorticoid Receptor Antagonists | 1 | 2024 | 55 | 0.210 |
Why?
| | Time Factors | 4 | 2019 | 6944 | 0.210 |
Why?
| | Diuretics | 1 | 2024 | 72 | 0.210 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2024 | 100 | 0.210 |
Why?
| | Body Weight | 1 | 2007 | 992 | 0.200 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2024 | 228 | 0.200 |
Why?
| | Congresses as Topic | 1 | 2024 | 223 | 0.190 |
Why?
| | Cost of Illness | 1 | 2024 | 310 | 0.180 |
Why?
| | Feeding Behavior | 1 | 2007 | 679 | 0.180 |
Why?
| | Acute Disease | 1 | 2024 | 1010 | 0.170 |
Why?
| | Middle Aged | 10 | 2024 | 34487 | 0.170 |
Why?
| | Survival Rate | 2 | 2017 | 1962 | 0.170 |
Why?
| | Waiting Lists | 1 | 2022 | 244 | 0.160 |
Why?
| | Societies, Medical | 1 | 2024 | 852 | 0.160 |
Why?
| | Income | 1 | 2020 | 198 | 0.150 |
Why?
| | Risk Assessment | 3 | 2019 | 3484 | 0.150 |
Why?
| | Resistance Training | 1 | 2022 | 168 | 0.150 |
Why?
| | Exercise | 3 | 2022 | 2108 | 0.150 |
Why?
| | Polypharmacy | 1 | 2019 | 89 | 0.150 |
Why?
| | Weight Loss | 1 | 2024 | 790 | 0.140 |
Why?
| | Heart Valve Prosthesis Implantation | 1 | 2020 | 185 | 0.140 |
Why?
| | Follow-Up Studies | 3 | 2019 | 5194 | 0.140 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2024 | 1598 | 0.140 |
Why?
| | Prosthesis Implantation | 1 | 2019 | 156 | 0.140 |
Why?
| | Walk Test | 1 | 2018 | 79 | 0.140 |
Why?
| | Risk Factors | 3 | 2019 | 10430 | 0.130 |
Why?
| | Empathy | 1 | 2019 | 178 | 0.130 |
Why?
| | Exercise Tolerance | 1 | 2019 | 280 | 0.130 |
Why?
| | Social Determinants of Health | 1 | 2020 | 273 | 0.130 |
Why?
| | Aging | 1 | 2007 | 1917 | 0.130 |
Why?
| | Life Style | 1 | 2019 | 478 | 0.130 |
Why?
| | Kidney | 1 | 2024 | 1475 | 0.120 |
Why?
| | Caregivers | 1 | 2024 | 940 | 0.120 |
Why?
| | Disability Evaluation | 1 | 2018 | 303 | 0.120 |
Why?
| | Survival Analysis | 1 | 2019 | 1320 | 0.120 |
Why?
| | Heart Transplantation | 1 | 2022 | 714 | 0.120 |
Why?
| | Prospective Studies | 2 | 2018 | 7749 | 0.110 |
Why?
| | Clinical Decision-Making | 1 | 2018 | 339 | 0.110 |
Why?
| | Surveys and Questionnaires | 3 | 2019 | 5931 | 0.110 |
Why?
| | Cognitive Dysfunction | 1 | 2019 | 408 | 0.100 |
Why?
| | Hemodynamics | 1 | 2019 | 1100 | 0.100 |
Why?
| | Cognition | 2 | 2019 | 1220 | 0.100 |
Why?
| | Emotions | 1 | 2019 | 575 | 0.100 |
Why?
| | Cardiac Surgical Procedures | 1 | 2019 | 587 | 0.100 |
Why?
| | Hospitals, Veterans | 1 | 2014 | 255 | 0.100 |
Why?
| | Databases, Factual | 1 | 2019 | 1441 | 0.100 |
Why?
| | Health Personnel | 1 | 2019 | 724 | 0.100 |
Why?
| | Cardiomyopathies | 1 | 2016 | 331 | 0.100 |
Why?
| | Patient Admission | 1 | 2014 | 203 | 0.090 |
Why?
| | Prognosis | 2 | 2020 | 4060 | 0.090 |
Why?
| | Retrospective Studies | 2 | 2020 | 16315 | 0.090 |
Why?
| | Attitude of Health Personnel | 1 | 2020 | 1175 | 0.090 |
Why?
| | Phenotype | 1 | 2020 | 3172 | 0.090 |
Why?
| | Severity of Illness Index | 1 | 2019 | 2898 | 0.090 |
Why?
| | Kaplan-Meier Estimate | 1 | 2013 | 907 | 0.090 |
Why?
| | Cognition Disorders | 1 | 2015 | 513 | 0.090 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2020 | 1395 | 0.080 |
Why?
| | Sex Factors | 1 | 2016 | 2051 | 0.080 |
Why?
| | Adult | 5 | 2024 | 39134 | 0.080 |
Why?
| | Disease Progression | 1 | 2016 | 2791 | 0.070 |
Why?
| | Colorado | 1 | 2019 | 4597 | 0.070 |
Why?
| | Cross-Sectional Studies | 1 | 2019 | 5645 | 0.070 |
Why?
| | Patient Discharge | 1 | 2014 | 930 | 0.070 |
Why?
| | Hunger | 1 | 2007 | 54 | 0.070 |
Why?
| | Adaptation, Psychological | 2 | 2024 | 678 | 0.060 |
Why?
| | Caloric Restriction | 1 | 2007 | 126 | 0.060 |
Why?
| | Body Mass Index | 2 | 2019 | 2374 | 0.060 |
Why?
| | Energy Intake | 1 | 2007 | 510 | 0.050 |
Why?
| | Comorbidity | 2 | 2019 | 1658 | 0.050 |
Why?
| | Body Composition | 1 | 2007 | 703 | 0.050 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2024 | 197 | 0.050 |
Why?
| | Adipose Tissue | 1 | 2007 | 645 | 0.050 |
Why?
| | Motor Activity | 1 | 2007 | 718 | 0.050 |
Why?
| | Community Health Services | 1 | 2024 | 232 | 0.050 |
Why?
| | Prescriptions | 1 | 2022 | 73 | 0.050 |
Why?
| | Energy Metabolism | 1 | 2007 | 930 | 0.040 |
Why?
| | Policy | 1 | 2022 | 145 | 0.040 |
Why?
| | Young Adult | 1 | 2017 | 13646 | 0.040 |
Why?
| | Inpatients | 1 | 2024 | 512 | 0.040 |
Why?
| | Guideline Adherence | 1 | 2024 | 553 | 0.040 |
Why?
| | Diet | 1 | 2007 | 1269 | 0.040 |
Why?
| | Contraindications, Procedure | 1 | 2019 | 12 | 0.040 |
Why?
| | Visual Analog Scale | 1 | 2019 | 35 | 0.040 |
Why?
| | Tissue Donors | 1 | 2022 | 405 | 0.040 |
Why?
| | Muscle Strength | 1 | 2022 | 327 | 0.040 |
Why?
| | Proportional Hazards Models | 1 | 2022 | 1261 | 0.040 |
Why?
| | Health Surveys | 1 | 2019 | 511 | 0.030 |
Why?
| | Cardiac Catheterization | 1 | 2020 | 540 | 0.030 |
Why?
| | Focus Groups | 1 | 2020 | 567 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2024 | 1536 | 0.030 |
Why?
| | Activities of Daily Living | 1 | 2019 | 425 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2020 | 1022 | 0.030 |
Why?
| | Cohort Studies | 1 | 2024 | 5789 | 0.030 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2019 | 622 | 0.020 |
Why?
| | Qualitative Research | 1 | 2020 | 1525 | 0.020 |
Why?
| | Stress, Psychological | 1 | 2019 | 1122 | 0.020 |
Why?
| | Incidence | 1 | 2015 | 2782 | 0.020 |
Why?
| | Adolescent | 1 | 2007 | 22027 | 0.020 |
Why?
| | Hypertension, Pulmonary | 1 | 2019 | 1940 | 0.020 |
Why?
|
|
Flint's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|